Search results
Biocon Foundation, IISc host OCTF conference to discuss progress of oral cancer screening for early...
The Economic Times· 20 hours agoBengaluru: Biocon Foundation in association with the Indian Institute of Science (IISc), recently...
Here's how much money Radhakishan Damani made in UltraTech Cement-India Cements deal
CNBC Awaaz· 24 hours agoAce investor Radhakishan Damani – along with his connected entities – has made a fortune in India...
Stock market update: Nifty Pharma index falls 0.62%
The Economic Times· 2 days agoThe Nifty Pharma index closed 0.62 per cent down at 21540.8.
Govt puts privatisation of Container Corporation of India on backburner
Business Standard India· 3 days agoThe government has put the privatisation of Container Corporation of India Ltd (Concor) on the...
Stock market update: Nifty Pharma index falls 0.17% in an upbeat market
The Economic Times· 3 days agoThe Nifty Pharma index was trading 0.17 per cent down at 21566.8.
Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus
Firstpost· 3 days agoKey stocks to watch include UltraTech Cement’s acquisition stake in India Cements, BHEL’s Rs 10,000...
Sensex surges over 1,150 points, Nifty tops 24,750; investor wealth jumps Rs 7.07L cr
Business Today· 6 days agoThe 30-share BSE Sensex pack rallied 1,171 points or 1.46 per cent to trade at 81,211, while the...
Biocon Ltd spurts 3.48%, gains for five straight sessions
Business Standard India· 6 days agoBiocon Ltd is quoting at Rs 374.45, up 3.48% on the day as on 12:44 IST on the NSE. The stock is up 46.21% in last one year as compared to a 25.73% gain in NIFTY and a 43.88% gain in the Nifty Pharma.
Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive - CNBC TV18
CNBC TV18· 6 days agoBengaluru-based Biocon Ltd. is likely to raise $500 million or over ₹4,000 crore by selling shares...
ETPharma to host second edition of Next-Gen LabCon themed, ‘Future-Ready Labs: Analog to Digital’ -...
The Economic Times· 7 days agoFuture Generation: The second edition of ETPharma’s Next-Gen LabCon will focus on the seamless progression of a product life cycle, heightened competition and building next-gen, future-ready ...